Name: Cencora Cost of Goods Sold 2010-2025 | COR
Creator: MACROTRENDS
License: https://creativecommons.org/licenses/by/4.0/

Warning: Undefined variable $sector_url in /var/www/html/macrotrends/public_html/production/stock_metadata.php on line 1234

Warning: Undefined variable $base_url in /var/www/html/macrotrends/public_html/production/stock_metadata.php on line 1245

Warning: Undefined variable $industry_url in /var/www/html/macrotrends/public_html/production/stock_metadata.php on line 1247

Warning: Undefined variable $base_url in /var/www/html/macrotrends/public_html/production/stock_metadata.php on line 1261
Cencora Cost of Goods Sold 2010-2025 | COR | MacroTrends

Cencora Cost of Goods Sold 2010-2025 | COR

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Cencora cost of goods sold for the twelve months ending March 31, 2025 was $299.711B, a 12.25% increase year-over-year.

Cencora annual cost of goods sold for 2024 was $284.049B, a 12.18% increase from 2023.
Cencora annual cost of goods sold for 2023 was $253.214B, a 9.95% increase from 2022.
Cencora annual cost of goods sold for 2022 was $230.291B, a 11.23% increase from 2021.

Cencora Cost of Goods Sold 2010-2025 | COR

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Cencora annual cost of goods sold for 2024 was $284.049B, a 12.18% increase from 2023.
Cencora annual cost of goods sold for 2023 was $253.214B, a 9.95% increase from 2022.
Cencora annual cost of goods sold for 2022 was $230.291B, a 11.23% increase from 2021.

Related Stocks
Company Name	Market Cap
Danaher (DHR)	$133.5B
Elevance Health (ELV)	$96.1B
CVS Health (CVS)	$84.8B
DiDi Global (DIDIY)	$20.3B
Natera (NTRA)	$20B
BioMerieux (BMXMF)	$15.6B
Solventum (SOLV)	$11.5B
ICON (ICLR)	$11.3B
EUROFINS SCIENT (ERFSF)	$11.1B
Revvity (RVTY)	$11B
CochLear (CHEOY)	$10.9B
Avantor (AVTR)	$10.3B
Doximity (DOCS)	$9.9B
Viatris (VTRS)	$9B
Medpace Holdings (MEDP)	$9B
Sonic Healthcare (SKHHY)	$7.7B
HealthEquity (HQY)	$7.3B
Charles River Laboratories (CRL)	$5.2B
Amplifon S.p.A (AMFPF)	$4.3B
Bausch + Lomb (BLCO)	$4.3B
Alignment Healthcare (ALHC)	$3.5B
Sotera Health (SHC)	$3B
BrightSpring Health Services (BTSG)	$2.9B
Organon (OGN)	$2.9B
Surgery Partners (SGRY)	$2.7B
GeneDx Holdings (WGS)	$2.7B
Concentras Parent (CON)	$2.6B
Progyny (PGNY)	$1.8B
Ardent Health Partners (ARDT)	$1.8B
Premier (PINC)	$1.8B